Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Bulls, Bears: The State Of CNS Companies In The Public MarketsOneMedPlace • Thu, Aug 16, 2012 -
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
What Makes InVivo An Attractive Takeover TargetTakeover Analyst • Fri, Feb 10, 2012 -
-
Here's Why We Like InVivo TherapeuticsJason Napodano • Thu, Jan 19, 2012
-
InVivo Soon To Enter Clinical TestingJason Napodano • Tue, Nov 15, 2011
-
-
-
-
-
-
-
-
Bulls, Bears: The State Of CNS Companies In The Public MarketsOneMedPlace • Thu, Aug 16, 2012
-
-
-
-
Record 1Q Sales: Nerve Regeneration Products Gaining TractionCockrell Group • Wed, May 16, 2012
-
Analyzing Wednesday's Noteworthy Insider TradesGuruFundPicks • Thu, Apr 12, 2012 -
-
-
-
-
-
-
Stocks To Watch This WeekVFC's Stock House • Wed, Nov 23, 2011
-
There are no Transcripts on NVIV.OB.
There are no News articles on NVIV.OB.
NVIV.OB vs. ETF Alternatives
Company Description
Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions. It intends to develop and commercialize biocompatible... More
